Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
about
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular LymphomasPretransplant FDG-PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis.Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphomaFluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis.Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.Transplantation for non-Hodgkin lymphoma.Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.Evolution of lymphoma staging and response evaluation: current limitations and future directions.Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.Guidelines for the management of diffuse large B-cell lymphoma.Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remiSpanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma
P2860
Q26752284-439DBCA9-2CB4-49C1-879C-E857F403A6BBQ30240084-E2BC1DCC-13D5-46DD-B1A5-50C1840A1923Q33416550-03FC69F8-B82D-46C1-96E0-08151A924474Q33824082-CE8849F7-5ED3-434E-9961-952B3A2ECDE5Q34355722-78C01ED8-2418-4684-8F7D-61D49DBE941EQ35626262-1927CF93-BE5C-461A-AAEE-10E02BFCDE38Q36021100-8CDBF2FB-D354-4F1E-A74A-91D9D6153813Q36219679-F29F001A-AF20-4850-A4EE-150B22084D00Q36929714-9C85C9B4-6313-4978-BE8E-F28256261A7FQ37618909-6C8AB47E-FABB-4876-9A1A-586C1D92B084Q37810079-A3F83C30-B057-41CD-B274-D0FAE1B86774Q38376595-538B5ADA-3643-4196-86E8-9A7CCC4E6F45Q38552083-457C4F14-9F2A-4BEB-9D53-18BAEC7848EBQ38671671-37B229F9-6632-4C4D-B1C9-778081A5305DQ44495190-7B641CA4-2007-4CD6-B7BF-0BE626B3ECB7Q48155873-099E7376-4EEB-43D8-88B3-77120FED67FDQ53099332-F4C59178-BD5D-4694-A7DF-D4837C5A6C07Q53137051-E83934B4-64BC-4722-BA74-8AA7B2D71104Q53137288-DA1BDB06-A409-4F23-AB58-003F933D7603Q54708579-9D48A4A0-8FAC-4AB5-96F1-18009A0CD7AFQ56973351-B1D5B31E-B4F1-49B8-95BD-C9DED857F781Q58767936-10EAB351-BA92-456E-833B-EC99853BD391
P2860
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@en
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@nl
type
label
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@en
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@nl
prefLabel
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@en
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@nl
P2093
P50
P356
P1433
P1476
Pretransplantation positron em ...... e B-cell non-Hodgkin lymphoma.
@en
P2093
Filippo Venturini
Lapo Alinari
Letizia Gandolfi
Monica Tani
Stefano Fanti
Vittorio Stefoni
P304
P356
10.1002/CNCR.23861
P407
P577
2008-11-01T00:00:00Z